Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro

Cancer Letters

Volumn 103, Issue 2, 1996, Pages 183-189

  Kurbacher, Christian M ^a,e   Wagner, Uwe ^a   Kolster, Bernd ^b   Andreotti, Peter E ^c   Krebs, Dieter ^a   Bruckner, Howard W ^d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Pascoe Parmazeutische Praparate GmbH   (Germany)

^c Atl Scientific Development Inc   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Ascorbic acid (vitamin C); ATP bioluminescence assay; Breast cancer; Cisplatin; Doxorubicin; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CISPLATIN; DOXORUBICIN; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029986515     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04212-7     Document Type: Article

References (32)

1. Park, C.H., Amare, M., Savin, M.A. and Hoogstraten, B. (1980) Growth suppression of human leukemic cells in vitro by L-ascorbic acid. Cancer Res., 40, 1062-1065.
2. Bram, S., Froussard, P., Guichard, M., Jasmin, C., Augery, Y., Sinoussi-Barre, F. and Wray, W. (1981) Vitamin C preferential toxicity for malignant melanoma cells. Nature, 284, 629-631.
3. 3 action. Cancer, 63, 901-906.
4. Begleiter, A (1983) Cytocidal action of the quinone group and its relationship to antitumor activity. Cancer Res., 43, 481-484.
5. Powis, G. (1989) Free radical formation by antitumor quinones. Free Rad. Biol. Med., 6, 63-101.
6. Lee, Y.S. and Wurster, R.D. (1995) Methylene blue induces cytotoxicity in human brain tumor cells. Cancer Lett., 88, 141-145.
7. Lown, J.W. (1985) Molecular mechanisms of action of anticancer agents involving free radical intermediates. Free Rad. Biol. Med., 1, 225-264.
8. Sinha, B.K. and Mimnaugh, E.G. (1990) Free radicals and anticancer drug resistance. Oxygen free radicals in the mechanism of drug cytotoxicity and resistance by certain tumors. Free Rad. Biol. Med., 8, 567-581.
9. Moertel, C.G., Fleming, T.R., Creagan, E.T., Rubin, J., O'Connell, M.J. and Ames, M.M. (1985) High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N. Engl. J. Med., 312, 137-141.
10. Prasad, K.N., Sinha, P.K., Ramamjam, M. and Sakamoto, A. (1979) Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc. Natl. Acad. Sci. USA, 76, 829-832.
11. Prasad, K.N., Hernandez, C., Edwards-Prasad, J., Nelson, J., Borus, T. and Robinson, W.A. (1994) Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr. Cancer, 22, 233-245.
12. Chiang, C.D., Song, E.J., Yang, V.C. and Chao, C.C. (1994) Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Biochem. J., 301, 759-764.
13. Prasad, S.B., Giri, A. and Arjun, J. (1992) Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma. Pol. J. Pharmacol, Pharm., 44, 383-391.
14. Haskell, C.M. (1995) Systemic treatment for metastatic breast cancer. In: Cancer Treatment, pp. 354-368. Editor: C.M. Haskell. W.B. Saunders, Philadelphia, PA.
15. Sinha, B.K., Katki, A.G., Batist, G., Cowan, K.H. and Myers, C.E. (1987) Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells. Biochem. Pharmacol., 36, 793-796.
16. Alberts, D.S. (1980) Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In: Cloning of Human Tumor Stem Cells. Editor: S.E. Salmon. Alan R. Liss, New York.
17. Kurbacher, C.M., Bruckner, H.W., Andreotti, P.E., Kurbacher, J.A., Sass, G. and Krebs, D. (1995) In vitro activity of titanocencdichloride versus cisplatin in four ovarian carcinoma cell lines evaluated by a microtiter plate ATP bioluminescence assay. Anti-Cancer Drugs, 6, 697-704.
18. Cameron, E. and Pauling, L. (1976) Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. USA, 73, 3685-3689.
19. Marquardt, H., Ruffing, F. and Weisburger, J.H. (1977) Mutagenic activity of nitrite treated foods: human stomach cancer may be related to dietary factors. Science, 196, 1000-1001.
20. Khan, P.K. and Sinha, S.P. (1993) Antimutagenic efficacy of higher doses of vitamin C. Mutat. Res., 298, 157-161.
21. Jain, M., Miller, A.B. and To, T. (1994) Premorbid diet and the prognosis of women with breast cancer. J. Natl. Cancer Inst., 86, 1390-1397.
22. 3 vitamin pretreatment. Int. J. Cancer, 40, 575-579.
23. Taper, H.S. and Roberfroid, M. (1992) Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin. Anti-cancer Res., 12, 1651-1654.
24. De Loecker, W., Janssens, J., Bonte, J. and Taper, H.S. (1993) Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human cell growth in vitro. II. Synergism with combined chemotherapy action. Anticancer Res., 13, 103-104.
25. Pething, R., Gascoyne, P.R.C., McLaughlin, J.A. and Szent-Gyorgyi, A. (1983) Ascorbate-quinone interactions: electrochemical, free radical and cytotoxic properties. Proc. Natl. Acad. Sci. USA, 80, 129-132.
26. Doroshow, J. (1986) Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents. Biochem. Biophys. Res. Commun., 135, 330-335.
27. Mimnaugh, E.G., Dusre, L., Atwell, J. and Myers, C.E. (1989) Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells. Cancer Res., 49, 8-15.
28. Shimpo, K., Nagatsu, T., Yamada, K., Sato, T., Niimi, H., Shamoto, M., Takeuchi, T., Umezawa, H. and Fujita, K. (1991) Ascorbic acid and adriamycin toxicity. Am. J Clin. Nutr., 54, 1298S-1301S.
29. Tonetti, M., Giovinc, M., Gasparim, A., Benatti, U. and De Flora, A. (1993) Enhanced formation of reactive species from cis-diammine-( 1,1 -cyclobutanedicarboxylato)-platinum(II) (carboplatin) in the presence of oxygen free radicals. Biochem. Pharmacol, 46, 1377-1383.
30. Gemba, M. and Fukuishi, N. (1991) Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal epithelial cells. Contrib. Nephrol., 95, 138-142.
31. Spencer, C.M. and Faulds, D. (1994) Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs, 48, 794-847.
32. Roy, S.N. and Horwitz, S.B. (1985) A phosphoglycoprotein associated with Taxol-resistance in J774.2 cells. Cancer Res., 45, 3856-3863.